ERYTHROID DIFFERENTIATION IS SUPPRESSED BY RIBAVIRIN DURING COMBINATION THERAPY WITH PEGYLATED INTERFERON-α2a IN CHRONIC HEPATITIS C: AN IN VITRO AND IN VIVO STUDY

被引：0
|
作者：
Aghemo, A. [1 ]
Ronzoni, L. [2 ]
Rumi, M. G. [1 ]
Prati, G. M. [1 ]
Monico, S. [1 ]
Colancecco, A. [2 ]
Grillo, P. [3 ]
Vigano, M. [1 ]
Cappellini, M. D. [2 ]
Colombo, M. [1 ]
机构：
[1] Univ Milan, Osped Maggiore Policlin, Fdn IRCCS, Div Gastroenterol 1, Milan, Italy
[2] Univ Milan, Osped Maggiore Policlin, Fdn IRCCS, Dept Internal Med, Milan, Italy
[3] Osped Maggiore Policlin, Fdn IRCCS, Dept Prevent Med, Epidemiol Unit, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60596-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
594
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 50 条
  • [1] Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C
    Oiso, Naoki
    Sato, Masako
    Kawada, Akira
    JOURNAL OF DERMATOLOGY, 2013, 40 (09): : 772 - 773
  • [2] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [3] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis CA Meta-Analysis
    Nicolas Flori
    Natalie Funakoshi
    Yohan Duny
    Jean-Christophe Valats
    Michael Bismuth
    Dimitri Christophorou
    Jean-Pierre Daurès
    Pierre Blanc
    Drugs, 2013, 73 : 263 - 277
  • [4] Viral kinetics of combination pegylated interferon-α 2A plus ribavirin in patients with hepatitis C cirrhosis
    Gane, EJ
    Holland, J
    Duxfield, J
    Gi, S
    Chapman, B
    Cornelius, D
    Bain, H
    HEPATOLOGY, 2002, 36 (04) : 357A - 357A
  • [5] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [6] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nobuhiro Aizawa
    Hirayuki Enomoto
    Tomoyuki Takashima
    Yoshiyuki Sakai
    Kazunari Iwata
    Naoto Ikeda
    Hironori Tanaka
    Yoshinori Iwata
    Masaki Saito
    Hiroyasu Imanishi
    Hiroko Iijima
    Shuhei Nishiguchi
    Journal of Gastroenterology, 2014, 49 : 1253 - 1263
  • [7] Erythema Annulare Centrifugum due to Pegylated Interferon-α-2a plus Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection
    Gonul, Muzeyyen
    Cakmak, Seray Kulcu
    Ozcan, Nimet
    Oguz, Isil Deniz
    Ozhamam, Esra
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2014, 18 (01) : 65 - 68
  • [8] Incidence of retinopathy in chronic Hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
    Kashif, Muhammad
    Saleem, Muhammad Khurram
    Farooka, Imran Khan
    Husnain, Amino
    Siddiqui, Arif Mahmood
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (01) : 174 - 177
  • [9] Studies of therapy with thymosin α1 in combination with pegylated interferon α2a and ribavirin in nonresponder patients with chronic hepatitis C
    Camerini, Roberto
    Ciancio, Alessia
    De Rosa, Alfonso
    Rizzetto, Mario
    THYMOSINS IN HEALTH AND DISEASE: FIRST INTERNATIONAL SYMPOSIUM, 2007, 1112 : 368 - 374
  • [10] Retinopathy with pegylated interferon alpha 2a and ribavirin during a chronic viral hepatitis C
    Ngatcha, G.
    Rouibaa, F.
    Majdouli, S.
    Arouah, A.
    Feqhi, A.
    Oubaaz, A.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2013, 7 (01): : 53 - 56
12345